Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on 2 Hydroxyacetophenone. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN101407780B details a novel site-directed mutagenesis method for producing high-purity (R)-phenylethylene glycol, offering significant cost and supply chain advantages.
Patent CN101993828B details a dual-enzyme system for (S)-phenyl glycol. Achieve 100% e.e. and reduced manufacturing costs with scalable biocatalysis.
Novel patent CN118638089B enables CO2-based flavonoid synthesis. Offers high yield, mild conditions, and supply chain advantages for pharmaceutical intermediates.
Patent CN101469318B details enzymatic synthesis achieving 100 percent e.e. purity. This report analyzes cost reduction in chiral chemical manufacturing and supply chain reliability for global buyers.
Patent CN104830704A details a recombinant Candida parapsilosis strain producing (R)-phenylethylene glycol with 99.9% ee. Offers cost reduction and supply reliability for pharma intermediates.
Patent CN104726355A details yeast spore biocatalysis for high-purity S-phenylethylene glycol. Offers cost reduction and supply reliability for pharmaceutical intermediates.
Patent CN101230363B details a novel recombinant E. coli strain for asymmetric synthesis. This report analyzes cost reduction and supply chain advantages for pharmaceutical intermediates.
Patent CN104774778A details recombinant Candida parapsilosis for high-purity (S)-phenylethylene glycol. Offers cost reduction and supply chain reliability for pharmaceutical intermediates.
Novel one-pot method using polyphosphoric acid offers high yields and short reaction times for scalable flavanone production.
Patent CN104830744A details a novel SD-AS coupled enzyme method for (R)-phenylglycol. Achieves 100% e.e. and 99.9% yield, offering significant cost reduction and supply reliability for pharmaceutical manufacturing.
Novel halogenation-fluorination route for 5-fluoro-2-hydroxyacetophenone. High yield, low waste, scalable process for beta-blocker intermediates.